Displaying drugs 851 - 875 of 2797 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Capmatinib | 412.428 C23H17FN6O | A kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping. | Kinase Inhibitor | |
Butoconazole | 411.776 C19H17Cl3N2S | An imidazole antifungal used to treat vulvovaginal candidiasis. | Imidazole Derivatives | |
Zinc phenolsulfonate | 411.7 C12H10O8S2Zn | An ingredient in ophthalmic solutions indicated in the treatment of minor irritation and conjunctivitis. | Not Annotated | |
Fesoterodine | 411.5769 C26H37NO3 | An antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. | Drugs for Urinary Frequency and Incontinence | |
Acetophenazine | 411.56 C23H29N3O2S | For the treatment of disorganized and psychotic thinking. Also used to help treat false perceptions (e.g. hallucinations or delusions.) | Phenothiazines With Piperazine Structure | |
Sacubitril | 411.498 C24H29NO5 | A neprilysin inhibitor used in combination with valsartan as an adjunct to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. | Neprilysin Inhibitor / Neprilysin, antagonists & inhibitors | |
Fluvastatin | 411.473 C24H26FNO4 | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Heptanoic Acids / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia / Indoles | |
Clobetasol | 410.907 C22H28ClFO4 | Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids. | Corticosteroids, Very Potent (Group IV) | |
Clocortolone | 410.907 C22H28ClFO4 | A corticosteroid used to treat inflammatory and pruritic dermatoses of the scalp. | Corticosteroids, Moderately Potent (Group II) | |
Squalene | 410.73 C30H50 | Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation... | Polyenes / Triterpenes | |
Piperacetazine | 410.58 C24H30N2O2S | Piperacetazine was an antipsychotic. | Heterocyclic Compounds, Fused-Ring / Sulfur Compounds | |
Risperidone | 410.4845 C23H27FN4O2 | A second-generation antipsychotic medication used to treat a number of mental health disorders including schizophrenia, bipolar mania, psychosis, or as an adjunct in severe depression. | Agents that produce hypertension / Neurotoxic agents | |
Flumethasone | 410.458 C22H28F2O5 | A corticosteroid used to treat contact dermatitis, atopic dermatitis, eczema, psoriasis, diaper rash, and other skin conditions. | Corticosteroids, Moderately Potent (Group II) | |
Diflorasone | 410.4515 C22H28F2O5 | A topical corticosteroid used to treat the symptoms of various inflammatory skin conditions that cause erythema, pruritus, and discomfort. | Corticosteroids, Potent (Group III) | |
Lemborexant | 410.425 C22H20F2N4O2 | A dual orexin antagonist indicated for the treatment of sleep-onset and/or sleep maintenance insomnia. | Orexin Receptor Antagonists | |
Ceftibuten | 410.425 C15H14N4O6S2 | A third-generation cephalosporin antibiotic commonly used in the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsillitis. | Anti-Bacterial Agents / Third-Generation Cephalosporins | |
Butaperazine | 409.59 C24H31N3OS | Butaperazine was approved in 1967 , and possibly discontinued in the 1980s . | Phenothiazines With Piperazine Structure | |
Zuranolone | 409.574 C25H35N3O2 | A neuroactive steroid drug used to treat postpartum depression | Central Nervous System Agents / Psychotropic Drugs | |
Ezetimibe | 409.4252 C24H21F2NO3 | A cholesterol absorption inhibitor used to lower total cholesterol, LDL-C, Apo-B, and non-HDL-C in primary hyperlipidemia and familial cholesterolemia. | Anticholesteremic Agents / Dietary Cholesterol Absorption Inhibitor / Hypolipidemic Agents Indicated for Hyperlipidemia | |
Alclometasone | 408.916 C22H29ClO5 | A topical corticosteroid used to relieve the symptoms of corticosteroid-responsive dermatoses. | Corticosteroids, Moderately Potent (Group II) | |
Clobetasone | 408.89 C22H26ClFO4 | A corticosteroid used to treat dry eyes, eczema, and dermatitis. | Corticosteroids, Moderately Potent (Group II) | |
Levamlodipine | 408.88 C20H25ClN2O5 | A calcium channel blocker used to treat hypertension. | Dihydropyridine Derivatives | |
Amlodipine | 408.876 C20H25ClN2O5 | A calcium channel blocker used to treat hypertension and angina. | ACE Inhibitors and Calcium Channel Blockers / Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Dihydropyridine Derivatives | |
Dapagliflozin | 408.873 C21H25ClO6 | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transport Proteins, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors | |
Cholic Acid | 408.5714 C24H40O5 | A bile acid used for the treatment of bile acid synthesis disorders due to single enzyme defects and as an adjunctive treatment of peroxisomal disorders with disrupted liver function. | Bile Acid Preparations / Bile acids and derivatives |
Displaying drugs 851 - 875 of 2797 in total